药明康德_2024 年业绩初步解读 —— 凭借大量积压订单，增长加速得到确认

更多资料加入知识星球：水木调研纪要 关注公众号：水木Alpha March 17, 2025 03:56 PM GMT WuXi AppTec Co Ltd | Asia Pacific 2024 Results First Take - Growth Acceleration Affirmed with Strong Backlog Reaction to earnings WuXi AppTec Co Ltd (2359.HK, 2359 HK) Unchanged In-line Largely unchanged Impact to our thesis Financial results versus consensus Direction of next 12-month consensus EPS Key Takeaways Financials: 2024 revenue of Rmb39.2bn (-2.7% y/y, or +5.2% y/y ex-Covid) and adj. net profit of Rmb10.6bn (-2.5% y/y) were in line with M ...